GTx Competitors and Similar CompaniesClear all
GTx's competitors and similar companies include Takeda, Cantex Pharmaceuticals and Oncoceutics.
 Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Cantex Pharmaceuticals Cantex Pharmaceuticals is a pharmaceutical company developing proprietary pharmaceuticals that improve the treatment of cancer. |  Oncoceutics Oncoceutics was a biotechnology company that developed small molecule compounds targeting G protein-coupled receptors for oncology applications. | ||
Founding Date | Founding Date 1997 | Founding Date 1781 | Founding Date 2002 | Founding Date 2009 |
Type | Type Subsidiary | Type Public | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Memphis, US HQ | Locations Weston, US HQ | Locations Philadelphia, US HQ | |
Employees | Employees 1148% decrease | Employees 47,4554% decrease | Employees 650% increase | Employees 12 |
Financial | ||||
Revenue (est.) | Revenue (est.) $4.3m (FY, 2021) | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($31.3m) (FY, 2021) | Net income ¥108.1b (FY, 2025) | Net income N/A | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 64.7m | Total funding raised $ 57.8m | Total funding raised $ 27.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyCantex Pharmaceuticals
HQ
Weston, US
Employees
6↑ 50% increase
Cantex Pharmaceuticals is a pharmaceutical company developing proprietary pharmaceuticals that improve the treatment of cancer.
View companyOncoceutics
HQ
Philadelphia, US
Oncoceutics was a biotechnology company that developed small molecule compounds targeting G protein-coupled receptors for oncology applications.
View company